A new report reveals the top cities that rise to the top for healthcare—and they’re probably not the cities you’d expect.
A Pacific Research Institute report revealed that the 340B program is in desperate need of reform, while 340B Health refutes damaging claims.
Make the rules work for, rather than, against you by relying on these five critical capabilities.
Shift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.
Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
A KPMG-Leavitt Partners report shows Medicare Advantage and Managed Medicaid are on slightly different trajectories. Expert Ash Shehata shares his predictions for both markets.
A University of Phoenix College of Health Professions survey has surprising findings about RNs and health administrator views on healthcare hacking.
The impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.
From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.